Anna González-Neira (Anna Gonzalez-Neira)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Pharmaceutics

Cancers

Breast cancer research and treatment

Cells

Centro Nacional de Investigaciones Oncológicas

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro Nacional de Investigaciones Oncológicas Sep 1o 2004

Spain

Head :: Human Genotyping Unit-CeGen

Publications

Rocio Nunez-Torres, Guillermo Pita, María Peña-Chilet, Daniel López-López, Jorge Zamora, Gema Roldán, Belén Herráez, Nuria Álvarez, María Rosario Alonso, Joaquín Dopazo, Anna González-Neira
A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact. Pharmaceutics 15 (4) (2023)
Rocio Nunez-Torres, Guillermo Pita, María Peña-Chilet, Daniel López-López, Jorge Zamora, Gema Roldán, Belén Herráez, Nuria Álvarez, María Rosario Alonso, Joaquín Dopazo, Anna González-Neira
A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact. Pharmaceutics 15 (4) (2023)
Rocio Nunez-Torres, Guillermo Pita, María Peña-Chilet, Daniel López-López, Jorge Zamora, Gema Roldán, Belén Herráez, Nuria Álvarez, María Rosario Alonso, Joaquín Dopazo, Anna González-Neira
A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact. Pharmaceutics 15 (4) (2023)
Rocio Nunez-Torres, Guillermo Pita, María Peña-Chilet, Daniel López-López, Jorge Zamora, Gema Roldán, Belén Herráez, Nuria Álvarez, María Rosario Alonso, Joaquín Dopazo, Anna González-Neira
A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact. Pharmaceutics 15 (4) (2023)
Gisella Figlioli, Amandine Billaud, Qin Wang, Manjeet K Bolla, Joe G Dennis, Michael Lush, Anders Kvist, Muriel A Adank, Thomas U Ahearn, Natalia N Antonenkova, Päivi Auvinen, Sabine Behrens, Marina Bermisheva, Natalia V Bogdanova, Stig E Bojesen, Bernardo Bonanni, Thomas Brüning, Nicola J Camp, Archie I Campbell, Jose E Castelao, Melissa H Cessna, null Nbcs Collaborators, Kamila Czene, Peter Devilee, Thilo Dörk, Mikael Eriksson, Peter Andreas Fasching, Henrik Flyger, Marike Gabrielson, Manuela Gago-Dominguez, Montserrat García-Closas, Gord Glendon, Encarna B Gómez Garcia, Anna González-Neira, Felix Grassmann, Pascal Guénel, Eric Hahnen, Ute Hamann, Peter Hillemanns, Maartje J Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, null kConFab Investigators, Anna Jakubowska, Elza K Khusnutdinova, Vessela N Kristensen, Annika Lindblom, Maria A Loizidou, Jan Lubiński, Arto Mannermaa, Tabea Maurer, Dimitrios Mavroudis, William G Newman, Nadia Obi, Mihalis I Panayiotidis, Paolo Radice, Muhammad Usman Rashid, Valerie Rhenius, Matthias Ruebner, Emmanouil Saloustros, Elinor J Sawyer, Marjanka K Schmidt, Rita K Schmutzler, Mitul Shah, Melissa C Southey, Ian Tomlinson, Thérèse Truong, Elke Maria van Veen, Camilla Wendt, Xiaohong R Yang, Kyriaki Michailidou, Alison M Dunning, Paul D P Pharoah, Douglas F Easton, Irene L Andrulis, Dafydd Gareth Evans, Antoinette Hollestelle, Jenny Chang-Claude, Roger L Milne, Paolo Peterlongo
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. Cancers 15 (13) (2023)
Aurora Gómez-Vecino, Roberto Corchado-Cobos, Adrián Blanco-Gómez, Natalia García-Sancha, Sonia Castillo-Lluva, Ana Martín-García, Marina Mendiburu-Eliçabe, Carlos Prieto, Sara Ruiz-Pinto, Guillermo Pita, Alejandro Velasco-Ruiz, María Carmen Patino-Alonso, M Purificación Galindo-Villardón, María Linarejos Vera-Pedrosa, José Jalife, Jian-Hua Mao, Guillermo Macías de Plasencia, Andrés Castellanos-Martín, María Del Mar Sáez-Freire, Susana Fraile-Martín, Telmo Rodrigues-Teixeira, Carmen García-Macías, Julie Milena Galvis-Jiménez, Asunción García-Sánchez, María Isidoro-García, Manuel Fuentes, Maria-Begoña Garcia-Cenador, Francisco Javier García-Criado, Juan Luis García Hernández, María Ángeles Hernández-García, Juan Jesús Cruz Hernández, César Augusto Rodríguez-Sánchez, Alejandro Martín García-Sancho, Estefanía Pérez-López, Pérez-Martínez Antonio, Federico Gutiérrez-Larraya, Antonio J Cartón, José Angel García-Saenz, Ana Patiño-García, Miguel Martin, Teresa Alonso-Gordoa, Christof Vulsteke, Lieselot Croes, Sigrid Hatse, Thomas Van Brussel, Diether Lambrechts, Hans P M W Wildiers, Hang Chang, Marina Holgado-Madruga, Anna González-Neira, Pedro Luis Sánchez, Jesús Pérez Losada
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. Cells 12 (15) (2023)
Alejandro Velasco-Ruiz, Rocio Nuñez-Torres, Guillermo Pita, Hans P M W Wildiers, Diether Lambrechts, Sigrid Hatse, Danielle Delombaerde, Thomas Van Brussel, M Rosario Alonso, Nuria Alvarez, Belen Herraez, Christof Vulsteke, Pilar Zamora, Teresa Lopez-Fernandez, Anna González-Neira
POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients. Pharmaceutics 13 (11) (2021)
Sara Ruiz-Pinto, Guillermo Pita, Miguel Martín, Teresa Alonso-Gordoa, Daniel R Barnes, María R Alonso, Belén Herraez, Purificación García-Miguel, Javier Alonso, Antonio Pérez-Martínez, Antonio J Cartón, Federico Gutiérrez-Larraya, José A García-Sáenz, Javier Benítez, Douglas F Easton, Ana Patiño-García, Anna González-Neira
Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients. Breast cancer research and treatment 167 (1) (2017)

Anna González-Neira.css-eqlu8i{font-size:small;padding-left:4px;} (Anna Gonzalez-Neira)

Publication Activity (10 Years)

Top Topics

Top Venues

Anna González-Neira (Anna Gonzalez-Neira)